Abstract:Background: According to histopathology, esophageal cancer can be divided into squamous cell carcinoma (SCC) and esophageal adenocarcinoma (adeno arcinoma). In China, 90% of esophageal cancer patients are squamous cell carcinoma. Cisplatin and fluaziridine are the main chemotherapy before and after surgery. Long-term drug treatment is often accompanied by the emergence of drug resistance of tumor cells. There are many mechanisms for the emergence of drug resistance of tumor cells, including the increase of drug efflux, the decrease of drug intake, the inhibition of cell apoptosis, and so on. This study aimed to investigate the key cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma (ESCC).Methods: Two datasets from the Gene Expression Omnibus (GEO) database (GSE86099 and GSE50224) were retrieved. We performed microRNA (miRNA) and messenger RNA (mRNA) expression analysis to identify differentially expressed genes (DEGs). The intersection of the downregulated miRNA targets and the upregulated mRNAs were used for Gene Ontology (GO) enrichment analysis, and survival risk was assessed using data from The Cancer Genome Atlas (TCGA).Results: There were 35 common genes, of which, based on GO enrichment, most were related to the cardiac muscle cell action. Four genes showed significant association with the estimated half-maximal inhibitory concentration (IC50) of paclitaxel: bone morphogenetic protein 1 (BMP1), dumbbell former 4 protein (DBF4), angiogenin (ANG), and MAP7 domain containing 2 (MAP7D2). Four risk factors (MP1, HIP1, ANG, and MAP7D2) were selected to generate a signature using least absolute shrinkage and selection operator (LASSO) regression. Protein-protein interaction (PPI) analysis showed guanine nucleotide-binding protein subunit beta 4 (GNB4), calcium voltage-gated channel auxiliary subunit beta 2 (CACNB2), and sodium voltage-gated channel alpha subunit 1 (SCN1A) were located at key positions of the network. Among potential risk genes, only the high expression of dedicator of cytokinesis 8 (DOCK8) was associated with poorer survival.Conclusions: The 35 oncogenes may be involved in mechanisms of chemotherapy resistance in ESCC, as well as the corresponding enrichment and regulatory network. The signature containing 4 key risk genes merits further investigation and may provide a deeper understanding of the molecular mechanisms in ESCC treatment failure.

Chemosensitive Gene of Breast Cancer:Progress in Reserch

Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

A Preliminary Study of Genes Related to Concomitant Chemoradiotherapy Resistance in Advanced Uterine Cervical Squamous Cell Carcinoma.

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

The Research Progress of the Association Between DNA Topoisomerase IIα(topo IIα) and Sensitivity to Chemotherapy for Breast Cancer

Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer

Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients.

Estrogen Receptor-Related Genes As An Important Panel Of Predictors For Breast Cancer Response To Neoadjuvant Chemotherapy

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

The Role of Estrogen and Estrogen Receptors in Chemoresistance.

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

[Correlation of the Methylation Status of CpG Islands in the Promoter Region of 10 Genes with the 5-Fu Chemosensitivity in 3 Breast Cancer Cell Lines].

Correlation between chemosensitivity and clinilcopathological features in 83 cases of colorectal cancer

Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer

Chemoresistance mechanisms of breast cancer and their countermeasures

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Expressions of the Genes Related to Chemotherapeutic Sensitivity in Non-Small Cell Lung Cancer and Their Correlation to Its Clinical Pathology

The Methylation Status of ABCC8, CHFR, BMP3B, LOX, PRSS21, RASSF1A Promoters Correlate with the Sensitivity of Three Breast Cancer Cell Strains to 5-FU.

Expression of epidermal growth factor receptor in breast carcinoma before and after chemotherapy and its significance

Identification of genes predicting chemoresistance and short survival in ovarian cancer

Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma